NCT07535268Recruiting
REPRESENT-PF Registry
Prospective Multicenter Registry on the Clinical Outcomes and Safety of PFA for Atrial Fibrillation in Underrepresented Minorities (REPRESENT-PF Registry)
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected will be standard of care.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 275 (estimated)
- First submitted
- 9 Apr 2026
- Start date
- 30 Mar 2026
- Primary completion date
- 1 Mar 2028
- Lead sponsor
- Vivek Reddy
- Diseases
- Atrial fibrillation
- NCT number
- NCT07535268
What you commit to
- Study type: Observational
- Planned participants: 275
- From 30 Mar 2026 to the primary completion date, 1 Mar 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Enrolled in an investigational drug or device clinical trial or any other trial with outlined treatment plan
Other
- Long standing persistent AF (AF \> 1 year duration)
- Repeat ablation, unless index ablation procedure was in the REPRESENT-PF registry
- Any known contra-indication to ablation procedure at the discretion of the investigator
Who the study is looking for
- All consecutive patients classified as racial or ethnic minorities undergoing ablation using Boston Scientific FDA approved PFA catheters for AF will be included.
- De novo ablation for symptomatic paroxysmal and persistent AF (Age ≥ 18) (unless it is a repeat for a patient whose index procedure is also in the registry) who are deemed to be candidates for AF ablation by the investigator.
- Able and willing to participate in baseline and follow up evaluation over the study period
- Willing and able to provide informed consent, if applicable.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Mount Sinai Hospital Coordinator of this site? Confirm its status | New York | United States | Recruiting |
| Valley Health System Coordinator of this site? Confirm its status | Winchester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.